| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069428 Pharmaceutically active isoindoline derivatives |
| 04/10/2003 | US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 04/10/2003 | US20030069297 4-aryl substituted indolinones |
| 04/10/2003 | US20030069294 Alpha-substituted carboxylic acid derivatives |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069244 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068280 Treatment of respiratory diseases |
| 04/10/2003 | US20030068279 Dispersible pharmaceutical-based dry powder composition comprising a therapeutically effective amount of pharmaceutical in combination with a pharmaceutically acceptable carrier |
| 04/10/2003 | US20030068278 Administering fine powder of active material; measured aerosol |
| 04/10/2003 | US20030066524 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462543A1 Glucagon-like peptides (glp-1) and treatment of respiratory distress |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300407A1 Carbamates derived from arylalkylamines |
| 04/09/2003 | EP1300153A1 Use of n-desulfated heparin for treating or preventing inflammations |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299356A1 Novel compounds |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299125A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| 04/09/2003 | EP1299107A2 Highly concentrated stable meloxicam solutions |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299010A1 Vitamin k and essential fatty acids |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1140055B1 Use of a 5ht 2a? and 5ht 2a/c? receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/09/2003 | EP0934280B1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
| 04/09/2003 | EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409767A Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409716A New amino propylphosphinic acid |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method |
| 04/09/2003 | CN1408408A Snoring stopping health pill |
| 04/09/2003 | CN1408393A External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis |
| 04/09/2003 | CN1408362A Nasopharynx liquid |
| 04/09/2003 | CN1408359A Lima liquid for curing nasopharyngeal disease |
| 04/09/2003 | CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544992 Carbonylamino pyrrolidine and piperidine derivatives |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544983 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544975 Mimetics that inhibit lipid peroxidation; for use in the treatment of diseases or disorders mediated by oxidative stress, such as asthma, inflammatory bowel disease, arthritis and vasculitis. |
| 04/08/2003 | US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c |
| 04/08/2003 | CA2065849C Vitamin d analogues |
| 04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |